Anti-PD-1/CBL-Bi ADC(Orum)

N/A

Report date: 2025/02/13 14:23:57

First In Class

Base Information

Drug NameAnti-PD-1/CBL-Bi ADC(Orum)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionE3 ubiquitin-protein ligase CBL-B inhibitorsProgrammed cell death protein 1 blockers

TargetsE3 ubiquitin-protein ligase CBL-BProgrammed cell death protein 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A